Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$112B
1-Year Return
19.76%
This Quarter Return
+4.14%
1 Year Return
+19.76%
3 Year Return
+56.91%
5 Year Return
+121.6%
10 Year Return
+261.3%
AUM
$177B
AUM Growth
+$18.5B
(+12%)
Cap. Flow
-$68.6B
Cap. Flow
% of AUM
-38.7%
Top 10 Holdings %
Top 10 Hldgs %
31.73%
Holding
3,029
New
62
Increased
1,133
Reduced
1,112
Closed
99
Top Buys
| 1 |
Elevance Health
ELV
|
+$294M |
| 2 |
Linde
LIN
|
+$244M |
| 3 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$192M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$146M |
| 5 |
Walt Disney
DIS
|
+$140M |
Top Sells
| 1 |
Pfizer
PFE
|
+$204M |
| 2 |
Cadence Design Systems
CDNS
|
+$196M |
| 3 |
JPMorgan Chase
JPM
|
+$175M |
| 4 |
Thomson Reuters
TRI
|
+$144M |
| 5 |
Costco
COST
|
+$144M |
Sector Composition
| 1 | Technology | 9.76% |
| 2 | Financials | 7.82% |
| 3 | Healthcare | 6.99% |
| 4 | Consumer Discretionary | 4.72% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Xencor
XNCR
$613M
| $2.42M | ﹤0.01% |
86,824
+13,878
| +19% | +$387K |
|
|
SILV
1327
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $2.42M | ﹤0.01% |
340,281
-4,650
| -1% | -$33.1K |
|
1328
Blackstone
BX
$142B
| $2.41M | ﹤0.01% |
27,385
+1,584
| +6% | +$139K |
|
1329
Azenta
AZTA
$1.36B
| $2.4M | ﹤0.01% |
53,897
-14,628
| -21% | -$653K |
|
1330
Boston Beer
SAM
$2.36B
| $2.4M | ﹤0.01% |
7,310
-300
| -4% | -$98.6K |
|
1331
Intellia Therapeutics
NTLA
$1.23B
| $2.39M | ﹤0.01% |
64,170
+323
| +0.5% | +$12K |
|
1332
ESAB
ESAB
$6.69B
| $2.37M | ﹤0.01% |
40,040
-1,481
| -4% | -$87.5K |
|
1333
Brighthouse Financial
BHF
$2.8B
| $2.35M | ﹤0.01% |
53,243
-2,483
| -4% | -$110K |
|
1334
Kyndryl
KD
$7.39B
| $2.35M | ﹤0.01% |
158,965
-5,530
| -3% | -$81.6K |
|
1335
Atkore
ATKR
$2.06B
| $2.34M | ﹤0.01% |
16,678
+124
| +0.7% | +$17.4K |
|
1336
Park Hotels & Resorts
PK
$2.39B
| $2.34M | ﹤0.01% |
188,971
-8,101
| -4% | -$100K |
|
1337
Methanex
MEOH
$3.04B
| $2.33M | ﹤0.01% |
50,201
-824
| -2% | -$38.3K |
|
1338
SLM Corp
SLM
$5.86B
| $2.33M | ﹤0.01% |
187,804
-14,783
| -7% | -$183K |
|
1339
Brookfield Infrastructure
BIPC
$4.76B
| $2.32M | ﹤0.01% |
50,405
+696
| +1% | +$32.1K |
|
1340
Ventyx Biosciences
VTYX
$164M
| $2.29M | ﹤0.01% |
68,279
+27,199
| +66% | +$911K |
|
1341
Cytokinetics
CYTK
$6.12B
| $2.28M | ﹤0.01% |
64,929
+4,546
| +8% | +$160K |
|
1342
Worthington Enterprises
WOR
$3.17B
| $2.28M | ﹤0.01% |
57,206
-1,556
| -3% | -$62K |
|
1343
iShares MSCI France ETF
EWQ
$391M
| $2.27M | ﹤0.01% |
60,036
-7,400
| -11% | -$280K |
|
|
AQUA
1344
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.27M | ﹤0.01% |
45,557
-2,344
| -5% | -$117K |
|
1345
Kymera Therapeutics
KYMR
$3.36B
| $2.25M | ﹤0.01% |
75,941
+10,955
| +17% | +$325K |
|
1346
Rambus
RMBS
$9.26B
| $2.24M | ﹤0.01% |
43,629
+660
| +2% | +$33.8K |
|
1347
SPS Commerce
SPSC
$4B
| $2.22M | ﹤0.01% |
14,582
+78
| +0.5% | +$11.9K |
|
1348
EPR Properties
EPR
$4.45B
| $2.21M | ﹤0.01% |
58,109
-2,540
| -4% | -$96.8K |
|
1349
Dana Inc
DAN
$2.76B
| $2.21M | ﹤0.01% |
146,773
-4,007
| -3% | -$60.3K |
|
1350
Akero Therapeutics
AKRO
$3.48B
| $2.21M | ﹤0.01% |
57,658
+2,415
| +4% | +$92.4K |
|